Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin

Background and Objectives: Aspirin (acetylsalicylic acid—ASA) is a first-line antiplatelet therapy provided to patients with coronary artery disease (CAD). However, it has been demonstrated that 20–30% of these patients are non-sensitive to their ASA therapy. ASA non-sensitivity is a phenomenon wher...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Medicina (Kaunas)
Glavni autori: Khan, Hamzah, Gallant, Reid, Jain, Shubha, Al-Omran, Mohammed, De Mestral, Charles, Greco, Elisa, Wheatcroft, Mark, Alazonni, Ashraf, Abdin, Rawand, Rand, Margaret L., Ni, Heyu, Qadura, Mohammad
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7600331/
https://ncbi.nlm.nih.gov/pubmed/33023261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina56100519
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items